Literature DB >> 11152588

Upconverting phosphor reporters in immunochromatographic assays.

J Hampl1, M Hall, N A Mufti, Y M Yao, D B MacQueen, W H Wright, D E Cooper.   

Abstract

Immunochromatographic assays have become popular diagnostic tools in a variety of settings because they are sensitive, fast, and easy to use. Here, we describe the use of a novel reporter, upconverting phosphors (UCP), in this assay format. UCP are submicron-sized, inorganic crystals that are excited with infrared light and that emit photons in the visible range depending on the ion composition of the crystal. Using human chorionic gonadotropin (hCG) as a model analyte to describe the properties of phosphors in immunochromatographic assays, a detection limit of 10 pg hCG in a 100-microl sample has been achieved on a regular basis, with occasional detection of 1 pg hCG. This represents at least a 10-fold improvement over conventional reporter systems such as colloidal gold or colored latex beads. Quantitation of analytes is possible over at least 3 orders of magnitude. Furthermore, an example is given of how UCP can be used for analyte multiplexing using a two-plexed wick for the detection of mouse IgG and ovalbumin. Thus, UCP lateral flow assays can be used for applications that are currently limited by assay sensitivity, and they can increase the probability of a diagnosis by verifying the presence of several analytes in the same sample. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152588     DOI: 10.1006/abio.2000.4902

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  44 in total

Review 1.  Immunological methods for detection and identification of infectious disease and biological warfare agents.

Authors:  Anne Harwood Peruski; Leonard F Peruski
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Highly spectral dependent enhancement of upconversion emission with sputtered gold island films.

Authors:  Hua Zhang; Di Xu; Yu Huang; Xiangfeng Duan
Journal:  Chem Commun (Camb)       Date:  2010-11-16       Impact factor: 6.222

Review 3.  Controlling upconversion nanocrystals for emerging applications.

Authors:  Bo Zhou; Bingyang Shi; Dayong Jin; Xiaogang Liu
Journal:  Nat Nanotechnol       Date:  2015-11       Impact factor: 39.213

Review 4.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Photochemical characterization of up-converting inorganic lanthanide phosphors as potential labels.

Authors:  Tero Soukka; Katri Kuningas; Terhi Rantanen; Ville Haaslahti; Timo Lövgren
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

6.  Upconversion from aqueous phase lanthanide chelates.

Authors:  Xudong Xiao; Jeanne P Haushalter; Gregory W Faris
Journal:  Opt Lett       Date:  2005-07-01       Impact factor: 3.776

7.  Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum.

Authors:  Paul L A M Corstjens; Lisette van Lieshout; Michel Zuiderwijk; Dieuwke Kornelis; Hans J Tanke; Andre M Deelder; Govert J van Dam
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

8.  A low-cost smartphone-based platform for highly sensitive point-of-care testing with persistent luminescent phosphors.

Authors:  Andrew S Paterson; Balakrishnan Raja; Vinay Mandadi; Blane Townsend; Miles Lee; Alex Buell; Binh Vu; Jakoah Brgoch; Richard C Willson
Journal:  Lab Chip       Date:  2017-03-14       Impact factor: 6.799

Review 9.  Optical imaging-guided cancer therapy with fluorescent nanoparticles.

Authors:  Shan Jiang; Muthu Kumara Gnanasammandhan; Yong Zhang
Journal:  J R Soc Interface       Date:  2009-09-16       Impact factor: 4.118

Review 10.  Nanotechnologies for noninvasive measurement of drug release.

Authors:  Thomas Moore; Hongyu Chen; Rachel Morrison; Fenglin Wang; Jeffrey N Anker; Frank Alexis
Journal:  Mol Pharm       Date:  2013-11-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.